Post-Marketing Clinical Study of REQUIP (Ropinirole Hydrochloride) Tablets in Patients With Parkinson's Disease- Evaluation of Long-Term Efficacy and Safety -
Latest Information Update: 30 Aug 2023
At a glance
- Drugs Ropinirole (Primary) ; Levodopa
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 11 Jun 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 11 Jun 2010 Actual patient number (123) added as reported by ClinicalTrials.gov.
- 11 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.